Siga Technologies Inc (NASDAQ:SIGA)

CAPS Rating: 3 out of 5

A bio-defense company engaged in the discovery, development and commercialization of products for use in defense against biological warfare agents such as Smallpox and Arenaviruses.

Results 1 - 20 of 46 : 1 2 3 Next »

Recs

0
Member Avatar NCTad (97.98) Submitted: 2/12/2015 11:25:58 AM : Outperform Start Price: $1.84 SIGA Score: +32.18

Pick at the behest of TMFDeej: http://caps.fool.com/Blogs/a-bankrupt-company-that-lost-a/1038300

Certainly not something I would bet the farm on, but intriguing.

Recs

0
Member Avatar TMFDeej (99.39) Submitted: 2/11/2015 3:23:34 PM : Outperform Start Price: $1.73 SIGA Score: +40.20

Now this is the most intriguing SA article that I have come across in a while. Some of the posters here should love it too because it's about a biotech company. Not just any biotech company, one that is involved in a court case (special situation number one) and that recently filed for bankruptcy (special situation number two).

I'll let you read the meat of the investment case yourself in the author's words. Suffice to say that I find the idea very compelling, with a current share price of $1.75, downside of $1.40 and upside of $15.

SIGA Technologies: Uncovering Hidden Value In Bankruptcy

http://seekingalpha.com/article/2901346-siga-technologies-uncovering-hidden-value-in-bankruptcy

Summary

•After an $195 million unfavorable court ruling against SIGA, the company's stock has been slammed and SIGA has filed for relief under the Chapter 11 bankruptcy code.

•Investors are most likely selling on panic and ignoring that SIGA's bankruptcy is non-insolvency driven, and primarily filed to allow an orderly appeal against PharmAthene.

•With only $2.5 million of outstanding debt, $110 million of cash on the balance sheet, and another $165 million expected, SIGA's equity should remain unscathed in a worst-case scenario.

•As the government's primary supplier of the Smallpox antiviral, SIGA has tremendous upside as it looks to renew its contract sometime over the next year or two.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 10/28/2013 6:27:47 AM : Outperform Start Price: $3.58 SIGA Score: -51.06

IHS pattern

Recs

0
Member Avatar Rilac (98.85) Submitted: 8/6/2013 10:07:31 AM : Outperform Start Price: $2.82 SIGA Score: -47.89

BARDA payment will be received in the third quarter.

Recs

0
Member Avatar sidiling (96.51) Submitted: 6/5/2013 4:15:02 PM : Outperform Start Price: $3.32 SIGA Score: -56.59

2.4 Billion contract? Even if it's half that's a lot of justification right there.

Recs

1
Member Avatar pavlos1971 (99.58) Submitted: 3/12/2013 8:47:31 PM : Outperform Start Price: $4.37 SIGA Score: -78.87

Today SIGA delivered the first 190K of 2M courses of Arestvyr, a smallpox treatment, to the US strategic stockpile. When it delivers 500K, it will start receiving payments. The total payment is set at 463M.

Recs

3
Member Avatar zzlangerhans (99.81) Submitted: 6/2/2012 10:53:22 AM : Outperform Start Price: $2.27 SIGA Score: -51.77

Welcome to the wild world of SIGA, where bad news is good news and vice versa. If ever there was a Costanza stock, this is it. Do your due diligence, then bet in the opposite direction. Yesterday, a Delaware court issued a final ruling confirming their earlier decision to award PharmAthene half of SIGA's future profits from the ST-246 contract and the stock went up 8% on a huge down day for small caps. But that was just a drop in the ocean compared to the market cap losses SIGA sustained after the ST-246 contract was actually awarded in 2011. Despite the legal blow, even half of the 433M contract is almost double SIGA's current market cap. In addition, BARDA has the option to increase the total contract to 2.8B. So if you want to profit from some severe volatility, buy some shares and hope for bad news.

Recs

0
Member Avatar KO2469 (< 20) Submitted: 9/27/2011 3:41:48 PM : Outperform Start Price: $2.78 SIGA Score: -91.20

They are the only company with a drug that actually meets the RFP. Siga's drug works...there are no other options.
I thought negotiating a deal wasn't "doing a deal". Nothing was signed? How can they be forced to share 50% of the upside for a 3M loan which they paid back in full with interest.

Recs

0
Member Avatar RBCruice (< 20) Submitted: 7/26/2011 8:41:05 AM : Outperform Start Price: $7.86 SIGA Score: -125.99

Tracking the insider buying of the directors and chief scientific officers, their sum total investments from 5/19/11 tally to 6.26 million dollars. They bought at a average of 13.33$ a share. Simply what this means is their product is heavily undervalued if their most informed are buying thousands of shares at $13+ a share. Another key component is the short sellers putting heavy downward stress on the stock. Yesterday SIGA hit its 52 week low. With a meeting with Goldman Sachs on Aug 2 discussing small cap healthcare and with earnings approaching august 1st, investors will see decent news as positive news. Lastly with the signing of the BARDA contract, the government should begin buying shortly ST-246 anti viral vaccinations for small pox. With the Debt ceiling proposal looming over the US, positive news potentially will yield FDI (foreign direct investment) especially since democrats want to shield medicare and medicaid and any other healthcare programs. Id give this stock 70% chance to pop as of august 1st earnings.

Recs

0
Member Avatar Euro247 (36.27) Submitted: 7/18/2011 1:22:44 PM : Outperform Start Price: $8.76 SIGA Score: -133.73

Following ZZ on this one

Recs

0
Member Avatar EclecticRecluse (80.68) Submitted: 5/16/2011 7:36:54 AM : Underperform Start Price: $14.97 SIGA Score: +141.00

Extremely High Price for Book Value

Recs

0
Member Avatar Scot00Mac (< 20) Submitted: 5/13/2011 7:59:03 PM : Outperform Start Price: $14.97 SIGA Score: -141.00

With the contract award, this stock is poised to take off. Figuring the amount of the award, w/ extensions, this stock should double.

Recs

0

Recs

0
Member Avatar stuartgordon69 (< 20) Submitted: 3/4/2011 9:10:38 AM : Outperform Start Price: $14.82 SIGA Score: -141.06

I reckon the odds are +- 50% that the stock will rocket 2-300% and 50% it will fall 50%; those are my kind of odds!

Recs

1
Member Avatar tsko (< 20) Submitted: 12/26/2010 10:51:13 PM : Outperform Start Price: $13.22 SIGA Score: -149.44

The contract with BARDA will come through and the stock will run.

Recs

0
Member Avatar ml6086 (< 20) Submitted: 12/22/2010 10:58:40 AM : Outperform Start Price: $13.87 SIGA Score: -149.96

They have the only drug that works against small pox.

Recs

0
Member Avatar Maribaza (93.67) Submitted: 10/13/2010 3:31:51 PM : Underperform Start Price: $12.34 SIGA Score: +158.20

39,39,16
55,91,59

Recs

0
Member Avatar bottomfeder (< 20) Submitted: 2/10/2010 3:06:42 PM : Outperform Start Price: $5.88 SIGA Score: -154.31

The competition is 3 years behind should the goverment wait for them? Israel preparing for something big war continuing and terrorists ramping up their efforts. Prospects for siga are still good and the excitement in december Scared alot of investors and made good for the ones who were in for a quick hit. I am staying on this rocket and don't want to be in the stands when it takes off. Patience!

Recs

0
Member Avatar 9windsurfer (< 20) Submitted: 11/13/2009 9:20:21 PM : Outperform Start Price: $6.86 SIGA Score: -154.70

Too much positive to list for SIGA but they are gearing up for commercialization of the product have presented to BARDA and the World Health Organization. SIGA has also finalized the market image and packaging of the commercial material.

Recs

1
Member Avatar patentprowler (< 20) Submitted: 9/15/2009 3:54:10 PM : Outperform Start Price: $8.10 SIGA Score: -169.46

Their technology is excellent and they have a strong patent position around their potential therapeutics.

Results 1 - 20 of 46 : 1 2 3 Next »

Featured Broker Partners


Advertisement